Institut Jules Bordet

Brussels, Brussels Capital 1070

1 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumor, Bladder Cancer, Carcinoma, Renal Cell, Cervix Cancer, Cytomegalovirus (CMV), Endometrium Cancer, Esophagus Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Lung Cancer (NSCLC), Metastatic Breast Cancer, Ovary Cancer

Studies at this site

• A Study of PYX-201 in Advanced Solid Tumors — Recruiting now
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir — Completed
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed